质子泵抑制剂长期使用的风险与获益:美国胃肠病学会专家综述与最佳实践建议
该综述评估长期使用质子泵抑制剂(PPI)在胃食管反流病(GERD)、巴雷特食管(BE)和非甾体抗炎药(NSAID)溃疡出血预防三种适应症中的风险与获益,基于专家意见和截至2016年7月的文献,采用改良GRADE方法,由美国胃肠病学会临床实践更新委员会审核,提出10条最佳实践建议。
要点
- GERD伴酸相关并发症者应使用PPI短期愈合、维持愈合和长期控制症状。
- 无并发症GERD对短期PPI有应答者应尝试停药或减量,不能减量者可考虑动态食管pH/阻抗监测。
- 长期PPI使用者应定期重新评估剂量,使用最低有效剂量,不常规使用益生菌或额外补充钙、维生素B12、镁,不常规筛查骨密度等。
核心结论
- 长期PPI治疗应基于适应症个体化评估,使用最低有效剂量,并定期重新评估必要性。
研究设计与样本
- 专家综述与最佳实践建议,基于专家意见及PubMed、EMbase和Cochrane图书馆截至2016年7月的相关文献,并查询clinicaltrials.gov,采用改良GRADE方法评估证据质量,经美国胃肠病学会临床实践更新委员会审核。
主要发现
- 最佳实践建议1:GERD伴酸相关并发症(即糜烂性食管炎或消化性狭窄)患者应使用PPI进行短期愈合、维持愈合和长期症状控制。
- 最佳实践建议2:无并发症GERD对短期PPI有应答者应随后尝试停药或减量;不能减量者应考虑动态食管pH/阻抗监测以区分GERD与功能性疾病,最佳候选者可能以非典型症状为主或无明确GERD易感性(如中心性肥胖、大食管裂孔疝)。
- 最佳实践建议3:巴雷特食管伴症状性GERD患者应长期使用PPI。
- 最佳实践建议4:无症状巴雷特食管患者应考虑长期使用PPI。
- 最佳实践建议5:持续使用NSAID且高危溃疡出血患者应使用PPI。
关键数值与推荐
- 最佳实践建议6:长期PPI剂量应定期重新评估,以处方最低有效剂量来控制病情。
- 最佳实践建议7:长期PPI使用者不应常规使用益生菌预防感染。
- 最佳实践建议8:长期PPI使用者不应常规将钙、维生素B12或镁的摄入量增加至超过推荐膳食 allowance(RDA)。
- 最佳实践建议9:长期PPI使用者不应常规筛查或监测骨密度、血清肌酐、镁或维生素B12。
- 最佳实践建议10:不应基于潜在风险选择特定PPI制剂。
临床怎么用
- 根据患者具体适应症(GERD伴并发症、无并发症GERD、巴雷特食管、NSAID出血预防)决定PPI使用,并定期评估剂量至最低有效剂量。
- 对无并发症GERD且短期PPI有效者,应尝试停药或减量,不能减量者可考虑动态食管pH/阻抗监测。
- 长期PPI使用者不常规使用益生菌、不额外补充钙/维生素B12/镁、不常规筛查骨密度等,不基于潜在风险选择特定制剂。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The purpose of this review is to evaluate the risks associated with long-term use of proton pump inhibitors (PPIs), focusing on long-term use of PPIs for three common indications: gastroesophageal reflux disease (GERD), Barrett's esophagus (BE), and non-steroidal anti-inflammatory drug (NSAID) bleeding prophylaxis. METHODS: The recommendations outlined in this review are based on expert opinion and on relevant publications from PubMed, EMbase, and the Cochrane library (through July 2016). To identify relevant ongoing trials, we queried clinicaltrials.gov. To assess the quality of evidence, we used a modified approach based on the GRADE Working Group. The Clinical Practice Updates Committee of the American Gastroenterological Association has reviewed these recommendations. Best Practice Advice 1: Patients with GERD and acid-related complications (ie, erosive esophagitis or peptic stricture) should take a PPI for short-term healing, maintenance of healing, and long-term symptom control. Best Practice Advice 2: Patients with uncomplicated GERD who respond to short-term PPIs should subsequently attempt to stop or reduce them. Patients who cannot reduce PPIs should consider ambulatory esophageal pH/impedance monitoring before committing to lifelong PPIs to help distinguish GERD from a functional syndrome. The best candidates for this strategy may be patients with predominantly atypical symptoms or those who lack an obvious predisposition to GERD (eg, central obesity, large hiatal hernia). Best Practice Advice 3: Patients with Barrett's esophagus and symptomatic GERD should take a long-term PPI. Best Practice Advice 4: Asymptomatic patients with Barrett's esophagus should consider a long-term PPI. Best Practice Advice 5: Patients at high risk for ulcer-related bleeding from NSAIDs should take a PPI if they continue to take NSAIDs. Best Practice Advice 6: The dose of long-term PPIs should be periodically reevaluated so that the lowest effective PPI dose can be prescribed to manage the condition. Best Practice Advice 7: Long-term PPI users should not routinely use probiotics to prevent infection. Best Practice Advice 8: Long-term PPI users should not routinely raise their intake of calcium, vitamin B12, or magnesium beyond the Recommended Dietary Allowance (RDA). Best Practice Advice 9: Long-term PPI users should not routinely screen or monitor bone mineral density, serum creatinine, magnesium, or vitamin B12. Best Practice Advice 10: Specific PPI formulations should not be selected based on potential risks.
引用
- Freedberg DE, Kim LS, Yang YX, et al. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017. PMID: 28257716. doi:10.1053/j.gastro.2017.01.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。